Amgen
AMGN
2,338 hedge funds and large institutions have $102B invested in Amgen in 2022 Q1 according to their latest regulatory filings, with 182 funds opening new positions, 982 increasing their positions, 831 reducing their positions, and 108 closing their positions.
76% more funds holding in top 10
Funds holding in top 10: 29 → 51 (+22)
69% more first-time investments, than exits
New positions opened: 182 | Existing positions closed: 108
18% more repeat investments, than reductions
Existing positions increased: 982 | Existing positions reduced: 831
7% more capital invested
Capital invested by funds: $95.3B → $102B (+$6.61B)
2% more funds holding
Funds holding: 2,294 → 2,338 (+44)
0.74% more ownership
Funds ownership: 75.34% → 76.08% (+0.74%)
5% less call options, than puts
Call options by funds: $1.81B | Put options by funds: $1.91B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.1B |
| 2 |
JP Morgan Chase
New York
|
+$464M |
| 3 |
CIAS
CFS Investment Advisory Services
Totowa,
New Jersey
|
+$291M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$288M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$217M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$856M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$449M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$432M |
| 4 |
Barclays
London,
United Kingdom
|
-$407M |
| 5 |
Goldman Sachs
New York
|
-$238M |
AMGN Hedge Fund Activity: Q1 2022 in Review
2,338 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2022, worth a combined $102B — up 6.9% from $95.3B a quarter earlier.
Buyers outnumbered sellers: 182 funds opened new AMGN positions and 108 closed out — a net gain of 74 holders — while 982 added to existing stakes and 831 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.1B. The largest seller was Capital Research Global Investors, cutting an estimated $856M.
- 2,338 institutional investors held Amgen (AMGN) as of Q1 2022, up from 2,294 in Q4 2021.
- Funds reported $102B of Amgen stock for Q1 2022, up 6.9% quarter-over-quarter.
- 182 funds opened new Amgen positions in Q1 2022 and 108 closed out, a net change of +74 holders.
- The largest Amgen buyer in Q1 2022 was Morgan Stanley, an estimated $1.1B added.
- The largest Amgen seller in Q1 2022 was Capital Research Global Investors, an estimated $856M sold.
Based on aggregated 13F filings for Q1 2022.